| Generic Name |
Brand Name |
Breast cancer subtype |
Breast cancer stage |
Where in the drug approval process is this treatment |
| Abemaciclib |
Verzenio |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved |
| Abemaciclib (with an Aromatase Inhibitor) |
Verzenio |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation |
| Abemaciclib (with endocrine therapy) |
Verenzio |
HR+ |
Stage 0, I, II, III |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Abemaciclib (with fulvestrant) |
Verzenio (with fulvestrant) |
HR+, HER2- |
Stage IV (metastatic) |
|
| Alpelisib |
Piqray |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation |
| Anastrozole |
Arimidex |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Capecitabine |
Xeloda, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Capivasertib |
Truqap |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Carboplatin |
Paraplatin |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Cisplatin |
Platinol, and various generic versions |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Cyclophosphamide |
Cytoxan, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Docetaxel |
Taxotere, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Doxorubicin |
Adriamycin, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Epirubicin |
Pharmorubicin, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Eribulin |
Halaven |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Everolimus |
Afinitor |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Exemestane |
Aromasin, and various generic versions |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Fluorouracil Injection |
Fluorouracil Injection, and various generic versions |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Fulvestrant |
Faslodex |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Gemcitabine |
Gemzar, and various generic versions |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Goserelin 10.8mg |
Zoladex |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Goserelin 3.6mg |
Zoladex |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Inavolisib |
Itovebi |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Letrozole |
Femara, and various generic versions |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Leuprolide |
Lupron, and various generic versions |
HR+ |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Megestrol |
Megace, and various generic versions |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Methotrexate |
Metoject |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Mitoxantrone |
Novantrone |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| nab-Paclitaxel |
Abraxane, and various generic versions |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Neratinib |
Nerlynx |
HR+, HER2+ |
Stage 0, I, II, III |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation |
| Olaparib |
Lynparza |
HR+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved |
| Olaparib |
Lynparza |
HR+, Triple Negative |
Stage 0, I, II, III |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Paclitaxel |
Taxol |
HR+, HER2+, Triple Negative |
Stage 0, I, II, III, Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Palbociclib (with an Aromatase Inhibitor) |
Ibrance, and various generic versions |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Palbociclib (with Fulvestrant) |
Ibrance, and various generic versions |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Pegylated Liposomal Doxorubicin |
Caelyx, and various generic versions |
HR+, HER2+, Triple Negative |
Stage IV (metastatic) |
Health Canada - Approved, Listed on Provincial/Territorial drug Formulary |
| Ribociclib (plus fulvestrant) |
Kisqali |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |
| Ribociclib (with Aromatase Inhibitor) |
Kisqali |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Ribociclib (with Aromatase Inhibitor) |
Kisqali |
HR+ |
Stage II, III |
Health Canada - Approved, CDA/INNESSS - Public funding review process , Listed on Provincial/Territorial drug Formulary |
| Sacituzumab govitecan |
Trodelvy |
HR+ |
Stage IV (metastatic) |
Health Canada - Approved, CDA/INNESSS - Public funding review process , PCPA - Provincial & territorial price negotiation, Listed on Provincial/Territorial drug Formulary |